Bollard Group LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1556218 BOSTON, MA

Position in ACRS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,618,616

-$802,763 QoQ

Shares Held

431,631

-46.3% QoQ

Ownership

0.309%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bollard Group LLC holds $12,667,574 across 4 Biotechnology names. ACRS ranks #2 (12.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECX	Tectonic Therapeutic, Inc.	302,953	$9,364,277
2	ACRS	Aclaris Therapeutics, Inc. This page	431,631	$1,618,616
3	PRME	Prime Medicine, Inc.	361,136	$1,256,753
4	VOR	Vor Biopharma Inc.	23,987	$427,928

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,618,616	431,631	-46.3%	Shares	Defined	2026-05-14
2025-12-31	$2,421,379	804,445	-34.4%	Shares	Defined	2026-02-13
2025-09-30	$2,328,404	1,225,476	-9.4%	Shares	Defined	2025-11-14
2025-06-30	$1,920,231	1,352,276	-5.0%	Shares	Defined	2025-08-13
2025-03-31	$2,178,989	1,424,176	—	Shares	Defined	2025-05-15
No filing history on record for this holder in this stock.